URGN - CIK 0001668243
UroGen Pharma Ltd. has filed 549 documents with the SEC between 2016 and 2026. The most frequent type is insider trade (182 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Quarterly report | 10-Q | 2025-08-07 | 2025-06-30 |
| Major company event | 8-K | 2025-08-07 | 2025-08-07 |
| SCHEDULE 13G | - | 2025-08-06 | - |
| SCHEDULE 13G/A | - | 2025-08-05 | - |
| Insider trade | 4 | 2025-07-30 | 2025-07-28 |
| Insider trade | 4 | 2025-07-30 | 2025-07-28 |
| Insider trade | 4 | 2025-07-30 | 2025-07-28 |
| Insider sale notice | 144 | 2025-07-29 | - |
| Insider sale notice | 144 | 2025-07-29 | - |
| SCHEDULE 13G/A | - | 2025-07-29 | - |
| SCHEDULE 13G/A | - | 2025-07-16 | - |
| Annual report to shareholders | ARS | 2025-07-16 | 2024-12-31 |
| Proxy statement | DEF 14A | 2025-07-15 | 2025-08-11 |
| Major company event | 8-K | 2025-07-03 | 2025-06-30 |
| SCHEDULE 13G | - | 2025-06-16 | - |
| Major company event | 8-K | 2025-06-13 | 2025-06-12 |
| SCHEDULE 13G | - | 2025-06-13 | - |
| Insider trade | 4 | 2025-06-11 | 2025-06-08 |
| Insider sale notice | 144 | 2025-06-10 | - |
| SCHEDULE 13D/A | - | 2025-06-09 | - |
| SCHEDULE 13G/A | - | 2025-05-15 | - |
| Quarterly report | 10-Q | 2025-05-12 | 2025-03-31 |
| Major company event | 8-K | 2025-05-12 | 2025-05-12 |
| SCHEDULE 13G/A | - | 2025-05-12 | - |
| Annual report (amended) | 10-K/A | 2025-04-30 | 2024-12-31 |
| SCHEDULE 13G/A | - | 2025-03-17 | - |
| Annual report | 10-K | 2025-03-10 | 2024-12-31 |
| Major company event | 8-K | 2025-03-10 | 2025-03-10 |
| Major company event | 8-K | 2025-02-20 | 2025-02-14 |
| SCHEDULE 13G/A | - | 2025-02-12 | - |
| SCHEDULE 13G/A | - | 2025-02-05 | - |
| Insider trade | 4 | 2025-02-04 | 2025-01-31 |
| Insider trade | 4 | 2025-02-04 | 2025-01-31 |
| Insider trade | 4 | 2025-02-04 | 2025-01-31 |
| Major company event | 8-K | 2025-01-14 | 2025-01-14 |
| Activist ownership stake (update) | SC 13D/A | 2024-11-18 | - |
| Passive ownership stake (update) | SC 13G/A | 2024-11-14 | - |
| Passive ownership stake (update) | SC 13G/A | 2024-11-14 | - |
| Passive ownership stake (update) | SC 13G/A | 2024-11-14 | - |
| Passive ownership stake (update) | SC 13G/A | 2024-11-14 | - |
| Passive ownership stake (update) | SC 13G/A | 2024-11-14 | - |
| Passive ownership stake (update) | SC 13G/A | 2024-11-13 | - |
| Passive ownership stake | SC 13G | 2024-11-12 | - |
| Passive ownership stake | SC 13G | 2024-11-08 | - |
| Quarterly report | 10-Q | 2024-11-06 | 2024-09-30 |
| Major company event | 8-K | 2024-11-06 | 2024-11-06 |
| Passive ownership stake | SC 13G | 2024-11-06 | - |
| Passive ownership stake | SC 13G | 2024-10-24 | - |
| Insider trade | 4 | 2024-10-09 | 2024-10-08 |
| New insider ownership | 3 | 2024-10-09 | 2024-10-08 |